MGMT and neoplasm: The pooled OR from three studies involving 99 patients with grade 3 and 84 patients with grade 1–2 ovarian carcinoma indicated that MGMT promoter methylation was not associated with tumor grade (OR = 1.13, 95% CI = 0.51–2.46, p = .767).